ACE gene in pregnancy complications: Insights into future vascular risk

References

• Visser S, Hermes W, Ket JC, et al. Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders. Am J Obstet Gynecol. 2014 [Epub ahead of print].
   Web of Science ®Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157–160.
   PubMed Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women–2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–1423.
   PubMed Web of Science ®Google Scholar
• Männistö T, Mendola P, Vääräsmäki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681–690.
   PubMed Web of Science ®Google Scholar
• Brown MC, Best KE, Pearce MS, et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1–19.
   PubMed Web of Science ®Google Scholar
• Ranthe MF, AndersenEA, Wohlfahrt J, et al. Pregnancy loss and later risk of atherosclerotic disease. Circulation. 2013; 127:75–1782.
   PubMed Web of Science ®Google Scholar
• Jacoby DS, Rader DJ. Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Arch Intern Med. 2003;163:1155–1164.
   PubMed Web of Science ®Google Scholar
• Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856–2869.
   PubMed Web of Science ®Google Scholar
• Mistry HD, Kurlak LO, Broughton Pipkin F. The placental renin-angiotensin system and oxidative stress in pre-eclampsia. Placenta. 2012;34:182–186.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168–175.
   PubMed Web of Science ®Google Scholar
• Palei AC, Spradley FT, Warrington JP, et al. Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology. Acta Physiol (Oxf)</i>. 2013;208:224–233.
   PubMed Web of Science ®Google Scholar
• Sticchi E, Romagnuolo I, Sofi F, et al. Association between polymorphisms of the renin angiotensin system and carotid stenosis. J Vasc Surg. 2011;54:467–473.
   PubMed Web of Science ®Google Scholar
• Li J, Wu X, Li X, et al. The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology. 2010;116:271–278.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu F, Wei Y, et al. Angiotensin converting enzyme insertion/deletion polymorphism and risk of pregnancy hypertensive disorders: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2012;13:184–195.
   PubMed Web of Science ®Google Scholar
• Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update. 2011;17:803–812.
   PubMed Web of Science ®Google Scholar
• European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–1701.
   Google Scholar
• Fatini C, Sofi F, Sticchi E, et al. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J. 2004;147:516–521.
   PubMed Web of Science ®Google Scholar
• Koch W, Latz W, Eichinger M, et al. Genotyping of the angiotensin I-converting enzyme gene insertion/deletion polymorphism by the TaqMan method. Clin Chem. 2005;51:1547–1549.
   PubMed Web of Science ®Google Scholar
• Foy CA, Rice GI, Ossei-Gerning N, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterized by coronary angiography. Hum Genet. 1997;100:420–425.
   PubMed Web of Science ®Google Scholar
• Siddiqui N, Hladunewich M. Understanding the link between the placenta and future cardiovascular disease. Trends Cardiovasc Med. 2011;21:188–193.
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001; 357:2002–2006.
   Google Scholar
• Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51:1034–1041.
   PubMed Web of Science ®Google Scholar
• Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343–1346.
   PubMed Web of Science ®Google Scholar
• Jeunemaitre X. Genetics of the human renin angiotensin system. J Mol Med. 2008;86:637–641.
   PubMed Web of Science ®Google Scholar
• Ishigami T, Umemura S, Iwamoto T, et al. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 1995;91:951–954.
   PubMed Web of Science ®Google Scholar
• Henrion D, Amant C, Benessiano J, et al. Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro. J Vasc Res. 1998;35:356–362.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Mozafari H, et al. Preeclampsia and angiotensin converting enzyme (ACE) I/D and angiotensin II type-1 receptor (AT1R) A1166C polymorphisms: association with ACE I/D polymorphism. J Renin Angiotensin Aldosterone Syst. 2013;14:174–180.
   PubMed Web of Science ®Google Scholar
• Su MT, Lin SH, Chen YC, et al. Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Thromb Haemost. 2013;109:8–15.
   PubMed Web of Science ®Google Scholar
• Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011;377:1331–1340.
   PubMed Web of Science ®Google Scholar
• Kidron D, Bernheim J, Aviram R. Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta 2009;30:700–704.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Giannubilo SR, Bezzeccheri V, et al. Amniotic levels of nitric oxide and vascular endothelial growth factor in pregnancy with subsequent intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol. 2004;114:162–165.
   PubMed Web of Science ®Google Scholar
• Shaik AP, Sultana A, Bammidi VK, et al. A meta-analysis of eNOS and ACE gene polymorphisms and risk of pre-eclampsia in women. J Obstet Gynaecol. 2011;31:603–607.
   PubMedGoogle Scholar
• Dai B, Liu T, Zhang B, et al. The polymorphism for endothelial nitric oxide synthase gene, the level of nitric oxide and the risk for pre-eclampsia: a meta-analysis. Gene. 2013;519:187–193.
   PubMed Web of Science ®Google Scholar
• Fatini C, Sticchi E, Gensini F, et al. Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens. 2006; 24:1823–1829.
   Google Scholar
• Ferrari F, Facchinetti F, Yin H, et al. Single-nucleotide polymorphisms in genes involved in placental function and unexplained stillbirth. Am J Obstet Gynecol. 2012;207(316):e1–e7.
   Google Scholar